Stay updated on Pfizer Press Releases

Sign up to get notified when there's something new on the Pfizer Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the Pfizer Press Releases page

  1. Check
    4 days ago
    Change Detected
    Summary
    Adds new Covid-19 and Vaccines categories and a new press release about FDA approval for the XFG-adapted COVID-19 vaccine on 08.27.2026. Removes the Medicines and Prescription Medicines categories and the HYMPAVZI press release from 06.08.2026, altering the archive's filtering options and historical listings.
    Difference
    2%
    Check dated 2026-08-29T20:18:16.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The archive gains a dedicated Press Release Archive heading and adds a new 08.14.2026 entry announcing EMA validation of Pfizer and Valneva’s Lyme disease vaccine candidate. It also removes the old 'Press Releases' and 'News' navigation items and deletes the 06.06.2026 Berobenatide press release from the archive.
    Difference
    2%
    Check dated 2026-08-16T00:29:03.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    A new August 4, 2026 press release entry is added to the archive, expanding the list of corporate news; the Finance/Financial categories and the older webcast invitation entry are removed from the listing.
    Difference
    1%
    Check dated 2026-08-08T23:28:12.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    Adds two July 2026 press releases to the archive: 07.30.2026 Pfizer Announces Positive Topline Phase 3 Results for LITFULO in Patients with Nonsegmental Vitiligo, and 07.29.2026 European Commission Authorizes Pfizer and BioNTech XFG-adapted COVID-19 Vaccine in the European Union. It also removes older May 2026 releases from the archive, reflecting archival maintenance.
    Difference
    8%
    Check dated 2026-08-01T20:10:29.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    A new press release entry about FDA priority review for TALZENNA Plus XTANDI in metastatic prostate cancer was added under Medicines and Prescription Medicines (07.22.2026). A research article regarding the LORBRENA CROWN trial was removed (05.29.2026).
    Difference
    1%
    Check dated 2026-07-25T17:11:28.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Difference
    2%
    Check dated 2026-07-11T14:21:57.000Z thumbnail image

Stay in the know with updates to Pfizer Press Releases

Enter your email address, and we'll notify you when there's something new on the Pfizer Press Releases page.